Pharmaceutical compositions and dosage forms of thalidomide
US9006267B2 · kind B2 · utility
0Cited by
17References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 21, 2006 |
| Grant date | Apr 14, 2015 |
| Priority date | — |
| Expiry date | Sep 22, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2031
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical compositions and single unit dosage forms of thalidomide and pharmaceutically acceptable stereoisomers, prodrugs, salts, solvates, hydrates, or clathrates are disclosed. Also disclosed are methods of treating, managing, and preventing diseases and conditions such as, but not limited to, leprosy, chronic graft-vs-host disease, rheumatoid arthritis, sarcoidosis, an inflammatory condition, inflammatory bowel disease, and cancer using the novel dosage forms disclosed herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.